Bank of Nova Scotia
HAE icon

Bank of Nova Scotia’s Haemonetics HAE Stock Holding History

Bank of Nova Scotia’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-59,200
Closed -$5.17M – 1014
2020
Q3 		$5.17M Buy
+59,200
New +$5.17M 0.01% 461
2016
Q2 		– Sell
-10,690
Closed -$374K – 745
2016
Q1 		$374K Hold
10,690
– – ﹤0.01% 535
2015
Q4 		$345K Hold
10,690
– – ﹤0.01% 578
2015
Q3 		$345K Buy
10,690
+4,190
+64% +$158K ﹤0.01% 501
2015
Q2 		$268K Hold
6,500
– – ﹤0.01% 509
2015
Q1 		$291K Buy
+6,500
New +$272K ﹤0.01% 490

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of Nova Scotia's HAE Position: Q4 2020 in Review

Bank of Nova Scotia sold out of Haemonetics (HAE) in Q4 2020, closing a stake of 59,200 shares — an estimated $5.17M sold.

Bank of Nova Scotia first reported a position in HAE in Q1 2015 and held it in 6 quarters. The position peaked at $5.17M in Q3 2020. 286 funds tracked by Wall St. Rank hold HAE as of Q4 2020.

  • Bank of Nova Scotia reported no remaining Haemonetics position as of Q4 2020 after selling out during the quarter.
  • Bank of Nova Scotia sold 59,200 Haemonetics shares in Q4 2020, an estimated $5.17M.
  • Bank of Nova Scotia first reported a position in Haemonetics in Q1 2015 and held it in 6 quarters.
  • Bank of Nova Scotia's Haemonetics position peaked at $5.17M in Q3 2020.
  • 286 funds tracked by Wall St. Rank held Haemonetics as of Q4 2020.

Based on Bank of Nova Scotia's 13F filing for Q4 2020, filed 11 Feb 2021.